Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hee Dong Han, Yeongseon Byeon, Tae Heung Kang, In Duk Jung, Jeong-Won Lee, Byung Cheol Shin, Young Joo Lee, Anil K Sood & Yeong-Min Park. (2016) Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy. International Journal of Nanomedicine 11, pages 5729-5742.
Read now
Read now
Articles from other publishers (24)
Lu Chen, Yuchen Wang, Qingqing Hu, Yuxi Liu, Xuchen Qi, Zhihua Tang, Haihong Hu, Nengming Lin, Su Zeng & Lushan Yu. (2023) Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment. Frontiers in Immunology 14.
Crossref
Crossref
T. L. Nekhaeva, A. A. Kamaletdinova, M. F. Lutfullin & T. V. Tabanskaya. (2023) Current approaches to quality assessment, non-clinical and clinical studies of dendritic cell vaccines in oncology. Biological Products. Prevention, Diagnosis, Treatment 23:2, pages 148-161.
Crossref
Crossref
Yan Zhao, Yuansong Bai, Meili Shen & Yapeng Li. (2022) Therapeutic strategies for gastric cancer targeting immune cells: Future directions. Frontiers in Immunology 13.
Crossref
Crossref
Cristiana Berti, Michele Graciotti, Alice Boarino, Chakradhar Yakkala, Lana E. Kandalaft & Harm‐Anton Klok. (2021) Polymer Nanoparticle‐Mediated Delivery of Oxidized Tumor Lysate‐Based Cancer Vaccines. Macromolecular Bioscience 22:2, pages 2100356.
Crossref
Crossref
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, Chandpreet Singh, Andrzej Mackiewicz & Mariusz Kaczmarek. (2021) Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance. Frontiers in Immunology 12.
Crossref
Crossref
Faisal Raza, Hajra Zafar, Shulei Zhang, Zul Kamal, Jing Su, Wei‐En Yuan & Qiu Mingfeng. (2021) Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy. Advanced Healthcare Materials 10:6, pages 2002081.
Crossref
Crossref
Quan Guo, Qing Yang, Jun Li, Guipeng Liu, Igor Nikoulin & Steve Jia. (2023) Advanced Clinical Trials of Dendritic Cell Vaccines in Ovarian Cancer. Journal of Investigative Medicine 68:7, pages 1223-1227.
Crossref
Crossref
Parham Jabbarzadeh Kaboli, Lingling Zhang, Shixin Xiang, Jing Shen, Mingxing Li, Yueshui Zhao, Xu Wu, Qijie Zhao, Hanyu Zhang, Ling Lin, Jianhua Yin, Yuanlin Wu, Lin Wan, Tao Yi, Xiang Li, Chi Hin Cho, Jing Li, Zhangang Xiao & Qinglian Wen. (2020) Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review. Current Medicinal Chemistry 27:28, pages 4673-4698.
Crossref
Crossref
Jun-O Jin, Gyurin Kim, Juyoung Hwang, Kyung Ho Han, Minseok Kwak & Peter C.W. Lee. (2020) Nucleic acid nanotechnology for cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:1, pages 188377.
Crossref
Crossref
Ondrej Palata, Nada Podzimkova Hradilova, Dagmar Mysiková, Beata Kutna, Hana Mrazkova, Robert Lischke, Radek Spisek & Irena Adkins. (2020) Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype. Immunology Letters 219, pages 46-53.
Crossref
Crossref
莉莉 马. (2020) The Role of Human Dendritic Cell Subsets in Antitumor Immunity. Advances in Clinical Medicine 10:03, pages 232-238.
Crossref
Crossref
Apostolos Sarivalasis, Caroline Boudousquié, Klara Balint, Brian J. Stevenson, Philippe O. Gannon, Emanuela Marina Iancu, Laetitia Rossier, Silvia Martin Lluesma, Patrice Mathevet, Christine Sempoux, George Coukos, Urania Dafni, Alexandre Harari, Michal Bassani-Sternberg & Lana E. Kandalaft. (2019) A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma. Journal of Translational Medicine 17:1.
Crossref
Crossref
Yanyan Huai, Md Nazir Hossen, Stefan Wilhelm, Resham Bhattacharya & Priyabrata Mukherjee. (2019) Nanoparticle Interactions with the Tumor Microenvironment. Bioconjugate Chemistry 30:9, pages 2247-2263.
Crossref
Crossref
Graça S Marques, Zélia Silva & Paula A. Videira. (2018) Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods. Biological Procedures Online 20:1.
Crossref
Crossref
CHARLOTTE DE Wolf, MARJA VAN DE BOVENKAMP & MARCEL HOEFNAGEL. (2018) Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy. Cytotherapy 20:11, pages 1289-1308.
Crossref
Crossref
Hong Yeol Yoon, Subramanian Tamil Selvan, Yoosoo Yang, Min Ju Kim, Dong Kee Yi, Ick Chan Kwon & Kwangmeyung Kim. (2018) Engineering nanoparticle strategies for effective cancer immunotherapy. Biomaterials 178, pages 597-607.
Crossref
Crossref
Vivek Subbiah, Ravi Murthy, David S. Hong, Robert M. Prins, Chitra Hosing, Kyle Hendricks, Deepthi Kolli, Lori Noffsinger, Robert Brown, Mary McGuire, Siquing Fu, Sarina Piha-Paul, Aung Naing, Anthony P. Conley, Robert S. Benjamin, Indreshpal Kaur & Marnix L. Bosch. (2018) Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers. Clinical Cancer Research 24:16, pages 3845-3856.
Crossref
Crossref
Hannah Frizzell, Jaehyung Park, Natacha Comandante Lou & Kim A. Woodrow. (2017) Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies. Cellular Immunology 311, pages 54-62.
Crossref
Crossref
Elias A. Kotteas & Konstantinos N. Syrigos. (2016) The expanding new era of cancer immunotherapy. Forum of Clinical Oncology 7:1, pages 1-3.
Crossref
Crossref
Laura Jeanbart & Melody A. Swartz. (2015) Engineering opportunities in cancer immunotherapy. Proceedings of the National Academy of Sciences 112:47, pages 14467-14472.
Crossref
Crossref
James Brady, Linhong Li, Angelia Viley, Pachai Natarajan, Cornell Allen, Rama Shivakumar, Meg Duskin & Madhusudan V Peshwa. (2015) Development of ‘enhanced’ potency immunotherapy products using nonviral approaches. Pharmaceutical Bioprocessing 3:7, pages 463-470.
Crossref
Crossref
Sébastien Anguille, Evelien L. Smits, Christian Bryant, Heleen H. Van Acker, Herman Goossens, Eva Lion, Phillip D. Fromm, Derek N. Hart, Viggo F. Van Tendeloo & Zwi N. Berneman. (2015) Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews 67:4, pages 731-753.
Crossref
Crossref
LINLIN SONG, MENG ZHUO, YUYAN TANG, XIAOHUA CHEN, YONGSHENG YU, ZHENGHAO TANG & GUOQING ZANG. (2015) Ubiquitin-modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro. Molecular Medicine Reports 12:1, pages 289-296.
Crossref
Crossref
Rahul Bhome, Marc D. Bullock, Hajir A. Al Saihati, Rebecca W. Goh, John N. Primrose, A. Emre Sayan & Alex H. Mirnezami. (2015) A top-down view of the tumor microenvironment: structure, cells and signaling. Frontiers in Cell and Developmental Biology 3.
Crossref
Crossref